ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Alpha-1 Lung Disease Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-23J9981
Home | Market Reports | Health| Health Conditions| Respiratory Conditions
Global Alpha 1 Lung Disease Market Insights Forecast to 2028
BUY CHAPTERS

Global Alpha-1 Lung Disease Market Research Report 2025

Code: QYRE-Auto-23J9981
Report
July 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Baxter
Astrazeneca plc
Grifols S A
Teva Pharmaceutical Industries
Boehringer Ingelheim
Kamada
GlaxoSmithKline PLC
CSL Behring
Takeda
LFB Biomedicaments
Abeona Therapeutics
Biogen
Vertex Pharmaceuticals
Baxalta
Arrowhead Research Corporation
ProBioGen
Chiesi Pharmaceuticals
Kedrion Group
ProMetic Life Sciences

Alpha-1 Lung Disease Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Alpha-1 Lung Disease Market

Alpha-1 Lung Disease Market

The global market for Alpha-1 Lung Disease was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Alpha-1 antitrypsin deficiency (A1AD) is a hereditary disorder characterized by low levels of a protein called alpha-1 antitrypsin (A1AT) which is found in the blood. This deficiency may predispose an individual to several illnesses and most commonly manifests as chronic obstructive pulmonary disease (including bronchiectasis) and liver disease (especially cirrhosis and hepatoma), or more rarely, as a skin condition called panniculitis. A1AD is also more frequent among individuals with Wegener’s granulomatosis, now called polyangiitis with granulomatosis. A deficiency of A1AT allows substances that break down proteins (so-called proteolytic enzymes) to attack various tissues of the body. The attack results in destructive changes in the lungs (emphysema) and may also affect the liver and skin. Alpha-1 antitrypsin is ordinarily released by specialized, granules within a type of white blood cells (called neutrophils or polymorphonuclear leukocytes) in response to infection or inflammation. Deficiency of alpha-1 antitrypsin results in unbalanced (i.e., relatively unopposed) rapid breakdown of proteins (protease activity), especially in the supporting elastic structures of the lungs. Over years, this destruction can lead to progressive emphysema and is accelerated by smoking, some occupational exposures, and likely by other genetic modifiers of this risk which remain incompletely understood.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Alpha-1 Lung Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alpha-1 Lung Disease.
The Alpha-1 Lung Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alpha-1 Lung Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alpha-1 Lung Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Alpha-1 Lung Disease Market Report

Report Metric Details
Report Name Alpha-1 Lung Disease Market
CAGR 5%
Segment by Type
  • Augmentation Therapy
  • Cystic Fibrosis(CF)
  • Non-CF Bronchiectasis(NCFB)
  • Other
Segment by Application
  • Hospitals
  • Specialty Clinics
  • Pharmacies
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Baxter, AstraZeneca, Grifols, Teva Pharmaceutical Industries, Boehringer Ingelheim, Kamada Ltd, GlaxoSmithKline, CSL Behring, Takeda, LFB Biomedicaments, Abeona Therapeutics, Biogen, Vertex Pharmaceuticals, Baxalta, Arrowhead Research Corporation, ProBioGen, Chiesi Pharmaceuticals, Kedrion Group, ProMetic Life Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Alpha-1 Lung Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Alpha-1 Lung Disease Market report?

Ans: The main players in the Alpha-1 Lung Disease Market are Pfizer, Baxter, AstraZeneca, Grifols, Teva Pharmaceutical Industries, Boehringer Ingelheim, Kamada Ltd, GlaxoSmithKline, CSL Behring, Takeda, LFB Biomedicaments, Abeona Therapeutics, Biogen, Vertex Pharmaceuticals, Baxalta, Arrowhead Research Corporation, ProBioGen, Chiesi Pharmaceuticals, Kedrion Group, ProMetic Life Sciences

What are the Application segmentation covered in the Alpha-1 Lung Disease Market report?

Ans: The Applications covered in the Alpha-1 Lung Disease Market report are Hospitals, Specialty Clinics, Pharmacies, Others

What are the Type segmentation covered in the Alpha-1 Lung Disease Market report?

Ans: The Types covered in the Alpha-1 Lung Disease Market report are Augmentation Therapy, Cystic Fibrosis(CF), Non-CF Bronchiectasis(NCFB), Other

Recommended Reports

Lung Disease Therapeutics

Pulmonary Diagnostic & Drugs

Rare & Genetic Disorders

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alpha-1 Lung Disease Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Augmentation Therapy
1.2.3 Cystic Fibrosis(CF)
1.2.4 Non-CF Bronchiectasis(NCFB)
1.2.5 Other
1.3 Market by Application
1.3.1 Global Alpha-1 Lung Disease Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Pharmacies
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alpha-1 Lung Disease Market Perspective (2020-2031)
2.2 Global Alpha-1 Lung Disease Growth Trends by Region
2.2.1 Global Alpha-1 Lung Disease Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Alpha-1 Lung Disease Historic Market Size by Region (2020-2025)
2.2.3 Alpha-1 Lung Disease Forecasted Market Size by Region (2026-2031)
2.3 Alpha-1 Lung Disease Market Dynamics
2.3.1 Alpha-1 Lung Disease Industry Trends
2.3.2 Alpha-1 Lung Disease Market Drivers
2.3.3 Alpha-1 Lung Disease Market Challenges
2.3.4 Alpha-1 Lung Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alpha-1 Lung Disease Players by Revenue
3.1.1 Global Top Alpha-1 Lung Disease Players by Revenue (2020-2025)
3.1.2 Global Alpha-1 Lung Disease Revenue Market Share by Players (2020-2025)
3.2 Global Alpha-1 Lung Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Alpha-1 Lung Disease Revenue
3.4 Global Alpha-1 Lung Disease Market Concentration Ratio
3.4.1 Global Alpha-1 Lung Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alpha-1 Lung Disease Revenue in 2024
3.5 Global Key Players of Alpha-1 Lung Disease Head office and Area Served
3.6 Global Key Players of Alpha-1 Lung Disease, Product and Application
3.7 Global Key Players of Alpha-1 Lung Disease, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Alpha-1 Lung Disease Breakdown Data by Type
4.1 Global Alpha-1 Lung Disease Historic Market Size by Type (2020-2025)
4.2 Global Alpha-1 Lung Disease Forecasted Market Size by Type (2026-2031)
5 Alpha-1 Lung Disease Breakdown Data by Application
5.1 Global Alpha-1 Lung Disease Historic Market Size by Application (2020-2025)
5.2 Global Alpha-1 Lung Disease Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Alpha-1 Lung Disease Market Size (2020-2031)
6.2 North America Alpha-1 Lung Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Alpha-1 Lung Disease Market Size by Country (2020-2025)
6.4 North America Alpha-1 Lung Disease Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alpha-1 Lung Disease Market Size (2020-2031)
7.2 Europe Alpha-1 Lung Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Alpha-1 Lung Disease Market Size by Country (2020-2025)
7.4 Europe Alpha-1 Lung Disease Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alpha-1 Lung Disease Market Size (2020-2031)
8.2 Asia-Pacific Alpha-1 Lung Disease Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Alpha-1 Lung Disease Market Size by Region (2020-2025)
8.4 Asia-Pacific Alpha-1 Lung Disease Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alpha-1 Lung Disease Market Size (2020-2031)
9.2 Latin America Alpha-1 Lung Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Alpha-1 Lung Disease Market Size by Country (2020-2025)
9.4 Latin America Alpha-1 Lung Disease Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alpha-1 Lung Disease Market Size (2020-2031)
10.2 Middle East & Africa Alpha-1 Lung Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Alpha-1 Lung Disease Market Size by Country (2020-2025)
10.4 Middle East & Africa Alpha-1 Lung Disease Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Alpha-1 Lung Disease Introduction
11.1.4 Pfizer Revenue in Alpha-1 Lung Disease Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Baxter
11.2.1 Baxter Company Details
11.2.2 Baxter Business Overview
11.2.3 Baxter Alpha-1 Lung Disease Introduction
11.2.4 Baxter Revenue in Alpha-1 Lung Disease Business (2020-2025)
11.2.5 Baxter Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Alpha-1 Lung Disease Introduction
11.3.4 AstraZeneca Revenue in Alpha-1 Lung Disease Business (2020-2025)
11.3.5 AstraZeneca Recent Development
11.4 Grifols
11.4.1 Grifols Company Details
11.4.2 Grifols Business Overview
11.4.3 Grifols Alpha-1 Lung Disease Introduction
11.4.4 Grifols Revenue in Alpha-1 Lung Disease Business (2020-2025)
11.4.5 Grifols Recent Development
11.5 Teva Pharmaceutical Industries
11.5.1 Teva Pharmaceutical Industries Company Details
11.5.2 Teva Pharmaceutical Industries Business Overview
11.5.3 Teva Pharmaceutical Industries Alpha-1 Lung Disease Introduction
11.5.4 Teva Pharmaceutical Industries Revenue in Alpha-1 Lung Disease Business (2020-2025)
11.5.5 Teva Pharmaceutical Industries Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Details
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim Alpha-1 Lung Disease Introduction
11.6.4 Boehringer Ingelheim Revenue in Alpha-1 Lung Disease Business (2020-2025)
11.6.5 Boehringer Ingelheim Recent Development
11.7 Kamada Ltd
11.7.1 Kamada Ltd Company Details
11.7.2 Kamada Ltd Business Overview
11.7.3 Kamada Ltd Alpha-1 Lung Disease Introduction
11.7.4 Kamada Ltd Revenue in Alpha-1 Lung Disease Business (2020-2025)
11.7.5 Kamada Ltd Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Alpha-1 Lung Disease Introduction
11.8.4 GlaxoSmithKline Revenue in Alpha-1 Lung Disease Business (2020-2025)
11.8.5 GlaxoSmithKline Recent Development
11.9 CSL Behring
11.9.1 CSL Behring Company Details
11.9.2 CSL Behring Business Overview
11.9.3 CSL Behring Alpha-1 Lung Disease Introduction
11.9.4 CSL Behring Revenue in Alpha-1 Lung Disease Business (2020-2025)
11.9.5 CSL Behring Recent Development
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Alpha-1 Lung Disease Introduction
11.10.4 Takeda Revenue in Alpha-1 Lung Disease Business (2020-2025)
11.10.5 Takeda Recent Development
11.11 LFB Biomedicaments
11.11.1 LFB Biomedicaments Company Details
11.11.2 LFB Biomedicaments Business Overview
11.11.3 LFB Biomedicaments Alpha-1 Lung Disease Introduction
11.11.4 LFB Biomedicaments Revenue in Alpha-1 Lung Disease Business (2020-2025)
11.11.5 LFB Biomedicaments Recent Development
11.12 Abeona Therapeutics
11.12.1 Abeona Therapeutics Company Details
11.12.2 Abeona Therapeutics Business Overview
11.12.3 Abeona Therapeutics Alpha-1 Lung Disease Introduction
11.12.4 Abeona Therapeutics Revenue in Alpha-1 Lung Disease Business (2020-2025)
11.12.5 Abeona Therapeutics Recent Development
11.13 Biogen
11.13.1 Biogen Company Details
11.13.2 Biogen Business Overview
11.13.3 Biogen Alpha-1 Lung Disease Introduction
11.13.4 Biogen Revenue in Alpha-1 Lung Disease Business (2020-2025)
11.13.5 Biogen Recent Development
11.14 Vertex Pharmaceuticals
11.14.1 Vertex Pharmaceuticals Company Details
11.14.2 Vertex Pharmaceuticals Business Overview
11.14.3 Vertex Pharmaceuticals Alpha-1 Lung Disease Introduction
11.14.4 Vertex Pharmaceuticals Revenue in Alpha-1 Lung Disease Business (2020-2025)
11.14.5 Vertex Pharmaceuticals Recent Development
11.15 Baxalta
11.15.1 Baxalta Company Details
11.15.2 Baxalta Business Overview
11.15.3 Baxalta Alpha-1 Lung Disease Introduction
11.15.4 Baxalta Revenue in Alpha-1 Lung Disease Business (2020-2025)
11.15.5 Baxalta Recent Development
11.16 Arrowhead Research Corporation
11.16.1 Arrowhead Research Corporation Company Details
11.16.2 Arrowhead Research Corporation Business Overview
11.16.3 Arrowhead Research Corporation Alpha-1 Lung Disease Introduction
11.16.4 Arrowhead Research Corporation Revenue in Alpha-1 Lung Disease Business (2020-2025)
11.16.5 Arrowhead Research Corporation Recent Development
11.17 ProBioGen
11.17.1 ProBioGen Company Details
11.17.2 ProBioGen Business Overview
11.17.3 ProBioGen Alpha-1 Lung Disease Introduction
11.17.4 ProBioGen Revenue in Alpha-1 Lung Disease Business (2020-2025)
11.17.5 ProBioGen Recent Development
11.18 Chiesi Pharmaceuticals
11.18.1 Chiesi Pharmaceuticals Company Details
11.18.2 Chiesi Pharmaceuticals Business Overview
11.18.3 Chiesi Pharmaceuticals Alpha-1 Lung Disease Introduction
11.18.4 Chiesi Pharmaceuticals Revenue in Alpha-1 Lung Disease Business (2020-2025)
11.18.5 Chiesi Pharmaceuticals Recent Development
11.19 Kedrion Group
11.19.1 Kedrion Group Company Details
11.19.2 Kedrion Group Business Overview
11.19.3 Kedrion Group Alpha-1 Lung Disease Introduction
11.19.4 Kedrion Group Revenue in Alpha-1 Lung Disease Business (2020-2025)
11.19.5 Kedrion Group Recent Development
11.20 ProMetic Life Sciences
11.20.1 ProMetic Life Sciences Company Details
11.20.2 ProMetic Life Sciences Business Overview
11.20.3 ProMetic Life Sciences Alpha-1 Lung Disease Introduction
11.20.4 ProMetic Life Sciences Revenue in Alpha-1 Lung Disease Business (2020-2025)
11.20.5 ProMetic Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Baxter
Astrazeneca plc
Grifols S A
Teva Pharmaceutical Industries
Boehringer Ingelheim
Kamada
GlaxoSmithKline PLC
CSL Behring
Takeda
LFB Biomedicaments
Abeona Therapeutics
Biogen
Vertex Pharmaceuticals
Baxalta
Arrowhead Research Corporation
ProBioGen
Chiesi Pharmaceuticals
Kedrion Group
ProMetic Life Sciences
List of Tables
 Table 1. Global Alpha-1 Lung Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Augmentation Therapy
 Table 3. Key Players of Cystic Fibrosis(CF)
 Table 4. Key Players of Non-CF Bronchiectasis(NCFB)
 Table 5. Key Players of Other
 Table 6. Global Alpha-1 Lung Disease Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Alpha-1 Lung Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Alpha-1 Lung Disease Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Alpha-1 Lung Disease Market Share by Region (2020-2025)
 Table 10. Global Alpha-1 Lung Disease Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Alpha-1 Lung Disease Market Share by Region (2026-2031)
 Table 12. Alpha-1 Lung Disease Market Trends
 Table 13. Alpha-1 Lung Disease Market Drivers
 Table 14. Alpha-1 Lung Disease Market Challenges
 Table 15. Alpha-1 Lung Disease Market Restraints
 Table 16. Global Alpha-1 Lung Disease Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Alpha-1 Lung Disease Market Share by Players (2020-2025)
 Table 18. Global Top Alpha-1 Lung Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-1 Lung Disease as of 2024)
 Table 19. Ranking of Global Top Alpha-1 Lung Disease Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Alpha-1 Lung Disease Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Alpha-1 Lung Disease, Headquarters and Area Served
 Table 22. Global Key Players of Alpha-1 Lung Disease, Product and Application
 Table 23. Global Key Players of Alpha-1 Lung Disease, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Alpha-1 Lung Disease Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Alpha-1 Lung Disease Revenue Market Share by Type (2020-2025)
 Table 27. Global Alpha-1 Lung Disease Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Alpha-1 Lung Disease Revenue Market Share by Type (2026-2031)
 Table 29. Global Alpha-1 Lung Disease Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Alpha-1 Lung Disease Revenue Market Share by Application (2020-2025)
 Table 31. Global Alpha-1 Lung Disease Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Alpha-1 Lung Disease Revenue Market Share by Application (2026-2031)
 Table 33. North America Alpha-1 Lung Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Alpha-1 Lung Disease Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Alpha-1 Lung Disease Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Alpha-1 Lung Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Alpha-1 Lung Disease Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Alpha-1 Lung Disease Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Alpha-1 Lung Disease Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Alpha-1 Lung Disease Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Alpha-1 Lung Disease Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Alpha-1 Lung Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Alpha-1 Lung Disease Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Alpha-1 Lung Disease Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Alpha-1 Lung Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Alpha-1 Lung Disease Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Alpha-1 Lung Disease Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Pfizer Company Details
 Table 49. Pfizer Business Overview
 Table 50. Pfizer Alpha-1 Lung Disease Product
 Table 51. Pfizer Revenue in Alpha-1 Lung Disease Business (2020-2025) & (US$ Million)
 Table 52. Pfizer Recent Development
 Table 53. Baxter Company Details
 Table 54. Baxter Business Overview
 Table 55. Baxter Alpha-1 Lung Disease Product
 Table 56. Baxter Revenue in Alpha-1 Lung Disease Business (2020-2025) & (US$ Million)
 Table 57. Baxter Recent Development
 Table 58. AstraZeneca Company Details
 Table 59. AstraZeneca Business Overview
 Table 60. AstraZeneca Alpha-1 Lung Disease Product
 Table 61. AstraZeneca Revenue in Alpha-1 Lung Disease Business (2020-2025) & (US$ Million)
 Table 62. AstraZeneca Recent Development
 Table 63. Grifols Company Details
 Table 64. Grifols Business Overview
 Table 65. Grifols Alpha-1 Lung Disease Product
 Table 66. Grifols Revenue in Alpha-1 Lung Disease Business (2020-2025) & (US$ Million)
 Table 67. Grifols Recent Development
 Table 68. Teva Pharmaceutical Industries Company Details
 Table 69. Teva Pharmaceutical Industries Business Overview
 Table 70. Teva Pharmaceutical Industries Alpha-1 Lung Disease Product
 Table 71. Teva Pharmaceutical Industries Revenue in Alpha-1 Lung Disease Business (2020-2025) & (US$ Million)
 Table 72. Teva Pharmaceutical Industries Recent Development
 Table 73. Boehringer Ingelheim Company Details
 Table 74. Boehringer Ingelheim Business Overview
 Table 75. Boehringer Ingelheim Alpha-1 Lung Disease Product
 Table 76. Boehringer Ingelheim Revenue in Alpha-1 Lung Disease Business (2020-2025) & (US$ Million)
 Table 77. Boehringer Ingelheim Recent Development
 Table 78. Kamada Ltd Company Details
 Table 79. Kamada Ltd Business Overview
 Table 80. Kamada Ltd Alpha-1 Lung Disease Product
 Table 81. Kamada Ltd Revenue in Alpha-1 Lung Disease Business (2020-2025) & (US$ Million)
 Table 82. Kamada Ltd Recent Development
 Table 83. GlaxoSmithKline Company Details
 Table 84. GlaxoSmithKline Business Overview
 Table 85. GlaxoSmithKline Alpha-1 Lung Disease Product
 Table 86. GlaxoSmithKline Revenue in Alpha-1 Lung Disease Business (2020-2025) & (US$ Million)
 Table 87. GlaxoSmithKline Recent Development
 Table 88. CSL Behring Company Details
 Table 89. CSL Behring Business Overview
 Table 90. CSL Behring Alpha-1 Lung Disease Product
 Table 91. CSL Behring Revenue in Alpha-1 Lung Disease Business (2020-2025) & (US$ Million)
 Table 92. CSL Behring Recent Development
 Table 93. Takeda Company Details
 Table 94. Takeda Business Overview
 Table 95. Takeda Alpha-1 Lung Disease Product
 Table 96. Takeda Revenue in Alpha-1 Lung Disease Business (2020-2025) & (US$ Million)
 Table 97. Takeda Recent Development
 Table 98. LFB Biomedicaments Company Details
 Table 99. LFB Biomedicaments Business Overview
 Table 100. LFB Biomedicaments Alpha-1 Lung Disease Product
 Table 101. LFB Biomedicaments Revenue in Alpha-1 Lung Disease Business (2020-2025) & (US$ Million)
 Table 102. LFB Biomedicaments Recent Development
 Table 103. Abeona Therapeutics Company Details
 Table 104. Abeona Therapeutics Business Overview
 Table 105. Abeona Therapeutics Alpha-1 Lung Disease Product
 Table 106. Abeona Therapeutics Revenue in Alpha-1 Lung Disease Business (2020-2025) & (US$ Million)
 Table 107. Abeona Therapeutics Recent Development
 Table 108. Biogen Company Details
 Table 109. Biogen Business Overview
 Table 110. Biogen Alpha-1 Lung Disease Product
 Table 111. Biogen Revenue in Alpha-1 Lung Disease Business (2020-2025) & (US$ Million)
 Table 112. Biogen Recent Development
 Table 113. Vertex Pharmaceuticals Company Details
 Table 114. Vertex Pharmaceuticals Business Overview
 Table 115. Vertex Pharmaceuticals Alpha-1 Lung Disease Product
 Table 116. Vertex Pharmaceuticals Revenue in Alpha-1 Lung Disease Business (2020-2025) & (US$ Million)
 Table 117. Vertex Pharmaceuticals Recent Development
 Table 118. Baxalta Company Details
 Table 119. Baxalta Business Overview
 Table 120. Baxalta Alpha-1 Lung Disease Product
 Table 121. Baxalta Revenue in Alpha-1 Lung Disease Business (2020-2025) & (US$ Million)
 Table 122. Baxalta Recent Development
 Table 123. Arrowhead Research Corporation Company Details
 Table 124. Arrowhead Research Corporation Business Overview
 Table 125. Arrowhead Research Corporation Alpha-1 Lung Disease Product
 Table 126. Arrowhead Research Corporation Revenue in Alpha-1 Lung Disease Business (2020-2025) & (US$ Million)
 Table 127. Arrowhead Research Corporation Recent Development
 Table 128. ProBioGen Company Details
 Table 129. ProBioGen Business Overview
 Table 130. ProBioGen Alpha-1 Lung Disease Product
 Table 131. ProBioGen Revenue in Alpha-1 Lung Disease Business (2020-2025) & (US$ Million)
 Table 132. ProBioGen Recent Development
 Table 133. Chiesi Pharmaceuticals Company Details
 Table 134. Chiesi Pharmaceuticals Business Overview
 Table 135. Chiesi Pharmaceuticals Alpha-1 Lung Disease Product
 Table 136. Chiesi Pharmaceuticals Revenue in Alpha-1 Lung Disease Business (2020-2025) & (US$ Million)
 Table 137. Chiesi Pharmaceuticals Recent Development
 Table 138. Kedrion Group Company Details
 Table 139. Kedrion Group Business Overview
 Table 140. Kedrion Group Alpha-1 Lung Disease Product
 Table 141. Kedrion Group Revenue in Alpha-1 Lung Disease Business (2020-2025) & (US$ Million)
 Table 142. Kedrion Group Recent Development
 Table 143. ProMetic Life Sciences Company Details
 Table 144. ProMetic Life Sciences Business Overview
 Table 145. ProMetic Life Sciences Alpha-1 Lung Disease Product
 Table 146. ProMetic Life Sciences Revenue in Alpha-1 Lung Disease Business (2020-2025) & (US$ Million)
 Table 147. ProMetic Life Sciences Recent Development
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Alpha-1 Lung Disease Picture
 Figure 2. Global Alpha-1 Lung Disease Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Alpha-1 Lung Disease Market Share by Type: 2024 VS 2031
 Figure 4. Augmentation Therapy Features
 Figure 5. Cystic Fibrosis(CF) Features
 Figure 6. Non-CF Bronchiectasis(NCFB) Features
 Figure 7. Other Features
 Figure 8. Global Alpha-1 Lung Disease Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Alpha-1 Lung Disease Market Share by Application: 2024 VS 2031
 Figure 10. Hospitals Case Studies
 Figure 11. Specialty Clinics Case Studies
 Figure 12. Pharmacies Case Studies
 Figure 13. Others Case Studies
 Figure 14. Alpha-1 Lung Disease Report Years Considered
 Figure 15. Global Alpha-1 Lung Disease Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Alpha-1 Lung Disease Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Alpha-1 Lung Disease Market Share by Region: 2024 VS 2031
 Figure 18. Global Alpha-1 Lung Disease Market Share by Players in 2024
 Figure 19. Global Top Alpha-1 Lung Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-1 Lung Disease as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Alpha-1 Lung Disease Revenue in 2024
 Figure 21. North America Alpha-1 Lung Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Alpha-1 Lung Disease Market Share by Country (2020-2031)
 Figure 23. United States Alpha-1 Lung Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Alpha-1 Lung Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Alpha-1 Lung Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Alpha-1 Lung Disease Market Share by Country (2020-2031)
 Figure 27. Germany Alpha-1 Lung Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Alpha-1 Lung Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Alpha-1 Lung Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Alpha-1 Lung Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Alpha-1 Lung Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Alpha-1 Lung Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Alpha-1 Lung Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Alpha-1 Lung Disease Market Share by Region (2020-2031)
 Figure 35. China Alpha-1 Lung Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Alpha-1 Lung Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Alpha-1 Lung Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Alpha-1 Lung Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Alpha-1 Lung Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Alpha-1 Lung Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Alpha-1 Lung Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Alpha-1 Lung Disease Market Share by Country (2020-2031)
 Figure 43. Mexico Alpha-1 Lung Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Alpha-1 Lung Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Alpha-1 Lung Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Alpha-1 Lung Disease Market Share by Country (2020-2031)
 Figure 47. Turkey Alpha-1 Lung Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Alpha-1 Lung Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Alpha-1 Lung Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Pfizer Revenue Growth Rate in Alpha-1 Lung Disease Business (2020-2025)
 Figure 51. Baxter Revenue Growth Rate in Alpha-1 Lung Disease Business (2020-2025)
 Figure 52. AstraZeneca Revenue Growth Rate in Alpha-1 Lung Disease Business (2020-2025)
 Figure 53. Grifols Revenue Growth Rate in Alpha-1 Lung Disease Business (2020-2025)
 Figure 54. Teva Pharmaceutical Industries Revenue Growth Rate in Alpha-1 Lung Disease Business (2020-2025)
 Figure 55. Boehringer Ingelheim Revenue Growth Rate in Alpha-1 Lung Disease Business (2020-2025)
 Figure 56. Kamada Ltd Revenue Growth Rate in Alpha-1 Lung Disease Business (2020-2025)
 Figure 57. GlaxoSmithKline Revenue Growth Rate in Alpha-1 Lung Disease Business (2020-2025)
 Figure 58. CSL Behring Revenue Growth Rate in Alpha-1 Lung Disease Business (2020-2025)
 Figure 59. Takeda Revenue Growth Rate in Alpha-1 Lung Disease Business (2020-2025)
 Figure 60. LFB Biomedicaments Revenue Growth Rate in Alpha-1 Lung Disease Business (2020-2025)
 Figure 61. Abeona Therapeutics Revenue Growth Rate in Alpha-1 Lung Disease Business (2020-2025)
 Figure 62. Biogen Revenue Growth Rate in Alpha-1 Lung Disease Business (2020-2025)
 Figure 63. Vertex Pharmaceuticals Revenue Growth Rate in Alpha-1 Lung Disease Business (2020-2025)
 Figure 64. Baxalta Revenue Growth Rate in Alpha-1 Lung Disease Business (2020-2025)
 Figure 65. Arrowhead Research Corporation Revenue Growth Rate in Alpha-1 Lung Disease Business (2020-2025)
 Figure 66. ProBioGen Revenue Growth Rate in Alpha-1 Lung Disease Business (2020-2025)
 Figure 67. Chiesi Pharmaceuticals Revenue Growth Rate in Alpha-1 Lung Disease Business (2020-2025)
 Figure 68. Kedrion Group Revenue Growth Rate in Alpha-1 Lung Disease Business (2020-2025)
 Figure 69. ProMetic Life Sciences Revenue Growth Rate in Alpha-1 Lung Disease Business (2020-2025)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Alpha Antitrypsin Deficiency Treatment Market Research Report 2025
Global Alpha 1 Antitrypsin Deficiency Augmentation Therapy Market Research Report 2024
Genetic COPD Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Alpha 1 Antitrypsin Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Alpha Thalassemia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lung Pulmonary Airway Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prolastin Market Insights Forecast to 2030
Alpha 1 Proteinase Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
5 Alpha Reductase Deficiency Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Emphysema Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chronic Lung Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Alport Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
COPD Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cystic Fibrosis CF Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Autoimmune Hemolytic Anemia Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drugs for Alport Syndrome Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chronic Obstructive Pulmonary Diseases Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Breathing Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Interstitial Lung Disease ILD Market Research Report 2024
Liver Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Inhaled Treatment for Asthma and COPD Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19Y19888
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Oxygen Inhaler Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11D3386
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Chronic Obstructive Pulmonary Disorder (COPD) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26D2937
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Bronchiectasis Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18E6080
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions